—
C+
C+ The full Closelook — membership. Open the C+ overview

Novonesis (Novozymes) A/S (NSIS-B.CO) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Novonesis (Novozymes) A/S

NSIS-B.CO in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Novonesis, formerly Novozymes, develops and supplies industrial enzymes, microorganisms and functional proteins used across food, agriculture, cleaning and bioenergy production. Its enzymes help turn crops into biofuel, improve detergents and support health and nutrition products. The company is based in Lyngby, Denmark, and serves customers across food and beverage, agriculture, household care and human health markets worldwide.
Where it sits in the stack
Novonesis carries no seat in our index; it sits in the specialty chemicals corner of the Basic Materials sector the diary tracks outside the build-out. Its work in industrial biotechnology and enzyme science falls well outside the layers we map for the AI hardware and infrastructure chain.
Who it is priced against
Closelook's peer group places it among other scored Basic Materials names, a broad sector comparison rather than a direct match, drawn from gold miners such as Barrick and AngloGold Ashanti. The market's closer comparison is International Flavors & Fragrances, whose Danisco unit competes directly in enzymes.
Why Closelook tracks it
It carries a Closelook score with momentum as its strongest module and valuation as its weakest, but holds no seat in our index and has not appeared in the diary's editions or quotes.
What the diary watches
Whether demand for bioenergy and industrial enzyme applications shifts enough to move the valuation module, given the gap between its momentum and valuation readings.

Novonesis (Novozymes) A/S (NSIS-B.CO) trades on the CO exchange in Denmark, classified under Basic Materials.

The Closelook company score reads 47/100 composite (momentum 69, quality 48, valuation 17) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for NSIS-B.CO, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Specialty Chemicals · 8 names with week and year-to-date

Peer group

Specialty Chemicals

Names in the same industry from the Closelook universe; scored names rank on their Closelook score, the rest on trend state.

Compared against NSIS-B.CO on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.54%, semi-annual · buybacks 100 m DKK in FY2025

Dividends and capital return

What NSIS-B.CO pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 6.60 DKK per share · a 1.54% yield on the 2026-09-18 close 2 distributions, paid twice a year 2026-09-18
  • Change on the year +2.3% against the prior twelve months prior twelve months 6.45 DKK per share
  • Last distribution 2.35 DKK per share as the price series records it, within days of the ex-date 2026-08-25
  • By calendar year 2025: 6.45 DKK (partial) · 2026: 6.60 DKK to date first distribution recorded in the three-year window: 2025-04-04
  • Dividends paid, FY2025 403 m DKK 49% of earnings
  • Buybacks, FY2025 100 m DKK 0.0% of today's market value
  • Share count +1.6% in FY2025 20 m DKK of stock-based compensation in the year
  • Capital returned 503 m DKK · 67% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sector × region Materials in Europe: −0.4% week · −2.9% month · −0.6% quarter · +10.3% year (approximated)The Sector Engine cell this name lives in, from EXV3.XETRA+EXH6.XETRA+EXH3.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-20
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Novonesis (Novozymes) A/S (NSIS-B.CO)?

Novonesis (Novozymes) A/S trades as NSIS-B.CO on the CO exchange (Denmark) and is classified under Basic Materials in the Closelook research universe, as of the registry build of 2026-09-19.

Is NSIS-B.CO in a Closelook index?

Not currently — Novonesis (Novozymes) A/S is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

What is Novonesis (Novozymes) A/S's Closelook composite score?

47 out of 100, with momentum 69, quality 48 and valuation 17 sub-scores, as of 2026-09-19. Scores are Closelook's own research readings, not ratings or investment advice.

Where does NSIS-B.CO trade against its moving averages?

Pullback inside an uptrend stack: Trades -0.1% vs the 50-day and +8.4% vs the 200-day average, 7.9% below the 52-week high and +29.4% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Novonesis (Novozymes) A/S do?

Novonesis, formerly Novozymes, develops and supplies industrial enzymes, microorganisms and functional proteins used across food, agriculture, cleaning and bioenergy production. Its enzymes help turn crops into biofuel, improve detergents and support health and nutrition products. The company is based in Lyngby, Denmark, and serves customers across food and beverage, agriculture, household care and human health markets worldwide. Closelook's peer group places it among other scored Basic Materials names, a broad sector comparison rather than a direct match, drawn from gold miners such as Barrick and AngloGold Ashanti. The market's closer comparison is International Flavors & Fragrances, whose Danisco unit competes directly in enzymes.

Where does Novonesis (Novozymes) A/S sit in the AI build-out?

Novonesis carries no seat in our index; it sits in the specialty chemicals corner of the Basic Materials sector the diary tracks outside the build-out. Its work in industrial biotechnology and enzyme science falls well outside the layers we map for the AI hardware and infrastructure chain. It carries a Closelook score with momentum as its strongest module and valuation as its weakest, but holds no seat in our index and has not appeared in the diary's editions or quotes.

Does Novonesis (Novozymes) A/S pay a dividend?

Novonesis (Novozymes) A/S has paid 6.60 DKK per share over the last twelve months, paid twice a year, a trailing yield of 1.54% on the 2026-09-18 close; the last distribution recorded in the price series was 2.35 DKK on 2026-08-25. In fiscal 2025 the company paid 403 m DKK in dividends and bought back 100 m DKK of its own shares, 67% of that year’s free cash flow. The share count rose 1.6% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for NSIS-B.CO, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Specialty Chemicals. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.